Protein discovery could improve type 2 diabetes treatment
A world first discovery of how a protein works in the liver could lead to a more effective type 2 diabetes drug.
Sep 2, 2020
0
140
A world first discovery of how a protein works in the liver could lead to a more effective type 2 diabetes drug.
Sep 2, 2020
0
140
New research evaluating the drugs commonly used by rheumatoid arthritis patients suggests two combinations could reduce the risk of heart attack and strokes.
Jul 6, 2021
0
2
Researchers from the Icahn School of Medicine at Mount Sinai have discovered a circuit in rats that links cigarette smoking and the risk of developing type 2 diabetes, according to a study featured on the cover of the October ...
Oct 16, 2019
0
140
The world's most commonly used Type 2 diabetes drug, Metformin, may be 'repurposed' to treat non-diabetic conditions according to researchers from the University of Dundee.
Aug 22, 2016
0
5
A new study published in the British Journal of Clinical Pharmacology provides insights on how common hospitalized patients develop liver injury from taking different medications.
May 5, 2021
0
3
Among nearly 120,000 adults with type 2 diabetes, there were no significant differences in the associations between any of 9 available classes of glucose-lowering drugs (alone or in combination) and the risk of cardiovascular ...
Jul 19, 2016
0
0
Hydroxychloroquine and azithromycin may have a serious impact on the cardiovascular system and are a potentially lethal combination, according to a large analysis of a World Health Organization (WHO) database on adverse drug ...
May 25, 2020
0
163
The antidepression drug duloxetine could be beneficial to patients with both depression and cardiovascular disease, according to new studies performed in human blood and in mice. Globally, more than 300 million people have ...
Apr 27, 2021
0
9
Although there have been cardiovascular safety concerns about attention-deficit/hyperactivity disorder (ADHD) medications because of their ability to increase heart rate and blood pressure levels, an analysis that included ...
Dec 12, 2011
0
0
(HealthDay)—The injectable drug Adlyxin (lixisenatide) has been approved to treat adults with type 2 diabetes, the U.S. Food and Drug Administration says.
Jul 28, 2016
0
5